BW

Humanigen Announces Peer-Reviewed Publication in The Journal of Medical Economics Demonstrating the Clinical and Economic Benefits of Lenzilumab

Lenzilumab plus standard of care (SOC), resulted in an estimated cost savings of $13,190 per patient (net savings of $3,190, after an assumed price of $10,000 for lenzilumab) in those receiving remdesivir with baseline C-Reactive Protein (CRP) levels <150 mg/L, and aged <85 years For COVID-19 patients requiring ICU admission…
Leer más...

United States Frozen Fish Market Report 2021-2027: Prospects, Trends Analysis, Market Size and Forecasts – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "United States Frozen Fish Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027" report has been added to ResearchAndMarkets.com's offering. The United States frozen fish market report provides deep insights into demand forecasts, market trends, and micro and macro indicators in the United States market. Also,…
Leer más...

Sonida Senior Living Announces December 2021 Occupancy

DALLAS--(BUSINESS WIRE)--$SNDA--Sonida Senior Living, Inc. (the “Company” or “Sonida Senior Living”) (NYSE: SNDA), a leading owner-operator of senior living communities and services announced its December 2021 occupancy. December Highlights December average occupancy increased 40 bps sequentially – in a typically slow seasonal period—from November 2021 to 81.6%—its highest point in…
Leer más...

United States Long-Acting Contraception Market Report 2021-2028: Focus on Intrauterine Devices, Subdermal Implants, Injectables – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "U.S. Long-acting Contraception Market Size, Share & Trends Analysis Report by Product (Intrauterine Devices, Subdermal Implants, Injectables), and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering. The U.S. long-acting contraception market size is expected to reach USD 2.5 billion by 2028 and is expected to expand…
Leer más...

ADC Therapeutics Announces Exclusive License with Mitsubishi Tanabe Pharma Corporation to Develop and Commercialize ZYNLONTA® (loncastuximab tesirine-lpyl) in Japan

ADC Therapeutics to receive $30 million upfront payment, up to $205 million in milestones, and double-digit royalties based on net sales in Japan LAUSANNE, Switzerland--(BUSINESS WIRE)--ADC Therapeutics SA (NYSE: ADCT), a commercial-stage biotechnology company improving the lives of those affected by cancer with its next-generation, targeted antibody drug conjugates (ADCs)…
Leer más...

United States Home Healthcare Services Market Size, Share & Trends Analysis Report 2021-2028 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "U.S. Home Healthcare Services Market Size, Share & Trends Analysis Report by Type (Skilled, Unskilled), and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering. The U.S. home healthcare services market size is expected to reach USD 175.7 billion by 2028. The market is expected to expand…
Leer más...

Arctic Wolf Establishes EMEA Headquarters in Newcastle

Fast-growing U.S. cybersecurity company heads to the North East to expand EMEA operations and tap into the region’s thriving base of technology talent NEWCASTLE, United Kingdom--(BUSINESS WIRE)--Arctic Wolf®, a global leader in security operations, has today announced the establishment of the company’s Europe, the Middle East and Africa (EMEA) headquarters…
Leer más...